More recent DSIP and DSIP-analogue research, involving modified compounds designed to behave similarly to DSIP, has explored possible neuroprotective and stroke-recovery roles in animal models, but this work remains preclinical rather than validated through large human therapeutic trials [1112][1819]
These basics drive 90%+ of body composition outcomes during weight loss
BPC-157 activates the VEGFR2-Akt-eNOS pathway, increasing blood vessel formation by 129% to 152% in damaged tissues according to preclinical studies
2021;54:797814.e796
As both an injectable and an oral pill, semaglutide functions by mimicking the natural hormone GLP-1, which helps reduce appetite and supports sustained weight loss
Additional Benefits: Reduced craving for food, decreased addictive behaviors, a significant reduction in major cardiac events (27% reduction in fatal heart attacks), 7% reduction in stroke, decreased occurrence of obesity-related cancers, improved fertility in both men and women, reduced heart failure rates, and increased survival in heart failure patients